EP4058453
Bætt efnasmíði á KRAS G12C hindra efnasambandi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.11.2020EP published:
24.12.2025EP application number:
20821492.4
EP translation filed:
27.2.2026Grant published:
11.3.2026EPO information:
European Patent Register
Max expiry date:
12.11.2040Expiry date:
12.11.2026
Title in English:
IMPROVED SYNTHESIS OF KRAS G12C INHIBITOR COMPOUNDLanguage of the patent:
English
Timeline
Today
13.11.2020EP application
24.12.2025EP Publication
27.2.2026Translation submitted
11.3.2026Registration published
12.11.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Inventor
Name:
PARSONS, Andrew T.Address:
Thousand Oaks, California 91320-1799, US
Name:
BEAVER, MatthewAddress:
Thousand Oaks, California 91320-1799, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962935502 PDate:
14.11.2019Country:
US
Classification
Categories:
C07D 471/04, C07F 5/02, C07F 5/05